Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial.

MLA

Armstrong, William B., et al. “Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial.” Cancer Prevention Research (Philadelphia, Pa.), vol. 6, no. 5, May 2013, pp. 410–18. EBSCOhost, https://doi.org/10.1158/1940-6207.CAPR-13-0004.

APA

Armstrong, W. B., Taylor, T. H., Kennedy, A. R., Melrose, R. J., Messadi, D. V., Gu, M., Le, A. D., Perloff, M., Civantos, F., Goodwin, W. J., Wirth, L. J., Kerr, A. R., & Meyskens, F. L., Jr. (2013). Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trial. Cancer Prevention Research (Philadelphia, Pa.), 6(5), 410–418. https://doi.org/10.1158/1940-6207.CAPR-13-0004

Chicago

Armstrong, William B, Thomas H Taylor, Ann R Kennedy, Raymond J Melrose, Diana V Messadi, Mai Gu, Anh D Le, et al. 2013. “Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial.” Cancer Prevention Research (Philadelphia, Pa.) 6 (5): 410–18. doi:10.1158/1940-6207.CAPR-13-0004.